Get the Stockscreener App
13.07
0.42%
-0.0604
Integra Lifesciences Holdings Corp stock is traded at $13.07, with a volume of 264.55K.
It is down -0.42% in the last 24 hours and down -1.25% over the past month.
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.
See More
Previous Close:
$13.13
Open:
$13.15
24h Volume:
264.55K
Relative Volume:
0.28
Market Cap:
$1.02B
Revenue:
$1.53B
Net Income/Loss:
$40.23M
P/E Ratio:
26.14
EPS:
0.5
Net Cash Flow:
$60.93M
1W Performance:
+5.27%
1M Performance:
-1.25%
6M Performance:
+2.55%
1Y Performance:
-40.97%
1-Day Range:
$12.93
$13.27
1-Week Range:
$11.86
$13.27
52-Week Range:
$10.87
$27.13
Integra Lifesciences Holdings Corp Stock (IART) Company Profile
Name
Integra Lifesciences Holdings Corp
Sector
Industry
Phone
(609) 275-0500
Address
1100 CAMPUS ROAD, PRINCETON, NJ
Compare IART with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IART
Integra Lifesciences Holdings Corp
|
13.08 | 1.02B | 1.53B | 40.23M | 60.93M | 0.50 |
|
ABT
Abbott Laboratories
|
127.06 | 222.19B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.64 | 144.97B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
367.09 | 140.12B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
99.56 | 128.60B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
84.52 | 49.82B | 5.88B | 1.34B | 799.60M | 2.3489 |
Integra Lifesciences Holdings Corp Stock (IART) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-31-25 | Upgrade | Argus | Hold → Buy |
| Dec-02-24 | Initiated | Morgan Stanley | Underweight |
| Oct-07-24 | Upgrade | BTIG Research | Sell → Neutral |
| Jul-30-24 | Downgrade | BTIG Research | Neutral → Sell |
| Jul-30-24 | Downgrade | Citigroup | Neutral → Sell |
| May-07-24 | Downgrade | Oppenheimer | Outperform → Perform |
| May-07-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-03-24 | Upgrade | Citigroup | Sell → Neutral |
| Dec-05-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Nov-14-23 | Initiated | CL King | Buy |
| Aug-24-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Jul-12-23 | Upgrade | Jefferies | Hold → Buy |
| Jun-08-23 | Downgrade | Argus | Buy → Hold |
| May-24-23 | Downgrade | JP Morgan | Neutral → Underweight |
| May-23-23 | Downgrade | Citigroup | Neutral → Sell |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Jul-25-22 | Initiated | Morgan Stanley | Equal-Weight |
| Apr-13-22 | Downgrade | Truist | Buy → Hold |
| Dec-17-21 | Upgrade | JP Morgan | Underweight → Neutral |
| Sep-15-21 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-08-20 | Downgrade | JP Morgan | Neutral → Underweight |
| May-27-20 | Initiated | Citigroup | Neutral |
| Apr-03-20 | Initiated | SunTrust | Buy |
| Jan-07-20 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Jan-07-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jan-03-19 | Initiated | SunTrust | Buy |
| Nov-28-18 | Initiated | UBS | Neutral |
| Aug-07-18 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jul-26-18 | Upgrade | BTIG Research | Neutral → Buy |
| Jul-02-18 | Downgrade | Citigroup | Buy → Neutral |
| Jan-05-18 | Resumed | Cantor Fitzgerald | Neutral |
| Jan-02-18 | Downgrade | BofA/Merrill | Buy → Neutral |
| Nov-09-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Oct-30-17 | Downgrade | Wells Fargo | Outperform → Market Perform |
| Oct-27-17 | Downgrade | JP Morgan | Overweight → Neutral |
| Jun-30-17 | Initiated | Cantor Fitzgerald | Overweight |
| May-02-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Jan-13-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Jan-06-17 | Upgrade | JMP Securities | Mkt Perform → Mkt Outperform |
| Dec-12-16 | Initiated | UBS | Buy |
View All
Integra Lifesciences Holdings Corp Stock (IART) Latest News
Integra LifeSciences to Present at 44th Annual J.P. Morgan Healthcare Conference - Quiver Quantitative
Integra LifeSciences Leadership to Present at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewswire
3 Reasons to Sell IART and 1 Stock to Buy Instead - Finviz
Halda Therapeutics Appoints Veteran Biopharma Leader, Christian Schade, as President and Chief Executive Officer - Quantisnow
At US$12.66, Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Worth Looking At Closely? - Yahoo Finance
Will Integra LifeSciences Holdings Corporation stock keep outperforming rivalsTrade Exit Summary & Real-Time Volume Triggers - Улправда
What Wall Street predicts for Integra LifeSciences Holdings Corporation stock price - Улправда
How geopolitical tensions affect Integra LifeSciences Holdings Corporation stockMarket Growth Summary & Weekly Return Optimization Plans - Улправда
How buybacks impact Integra LifeSciences Holdings Corporation stock valueQuarterly Earnings Summary & Consistent Income Trade Recommendations - DonanımHaber
How Integra LifeSciences Holdings Corporation (IL3) stock reacts to fiscal policiesJuly 2025 Price Swings & Low Drawdown Momentum Trade Ideas - ulpravda.ru
Why Integra LifeSciences Holdings Corporation stock is considered a top pickPortfolio Update Summary & Fast Gaining Stock Reports - DonanımHaber
How supply shortages influence Integra LifeSciences Holdings Corporation (IL3) stockWeekly Profit Summary & Long-Term Capital Growth Ideas - Улправда
Is Integra LifeSciences Holdings Corporation stock resilient to inflation2025 Key Highlights & Community Verified Watchlist Alerts - Улправда
What valuation multiples suggest for Integra LifeSciences Holdings Corporation stockJuly 2025 Price Swings & Low Risk High Reward Trade Ideas - DonanımHaber
Why Integra LifeSciences Holdings Corporation (IL3) stock is favored by hedge fundsWeekly Market Report & Consistent Profit Alerts - DonanımHaber
Why Integra LifeSciences Holdings Corporation stock could outperform in 2025 - Улправда
Will Integra LifeSciences Holdings Corporation stock maintain dividend yield2025 Volume Leaders & High Yield Equity Trading Tips - Улправда
Integra LifeSciences Holdings Corporation (NASDAQ:IART) Given Consensus Rating of "Reduce" by Brokerages - MarketBeat
Integra LifeSciences Holdings (NASDAQ:IART) Nasdaq Index Procedural Tools - Kalkine Media
Is Integra LifeSciences (IART) Undervalued After Its Recent Share Price Rebound? - simplywall.st
Integra LifeSciences (NASDAQ: IART) adopts renewed CIC severance plan - Stock Titan
Holdings of Integra Lifesciences Holdings Corp (IART) are aligned with the stars - setenews.com
How Integra LifeSciences Holdings Corporation (IL3) stock responds to bond marketWeekly Trade Summary & Accurate Entry and Exit Point Alerts - Newser
Will Integra LifeSciences Holdings Corporation (IL3) stock test record highs in 2025Forecast Cut & AI Based Buy and Sell Signals - Newser
Adversity is less terrifying than hope: Integra Lifesciences Holdings Corp (IART) - Setenews
Integra LifeSciences Leadership to Present at the Citi 2025 Global Healthcare Conference - The Manila Times
Integra LifeSciences (Nasdaq: IART) slated for Citi 2025 Global Healthcare Conference - Stock Titan
How does Integra Lifesciences Holdings Corp (IART) change from a tortoise to a hare? - Setenews
A Fresh Look at Integra LifeSciences (IART) Valuation After Recent Share Price Volatility - Yahoo Finance
Why Integra LifeSciences Holdings (IART) Is Up 17.7% After Medicare Expands Reimbursement for Skin Substitutes - simplywall.st
Integra LifeSciences Drops After Cutting Revenue Outlook - Finimize
Integra LifeSciences (IART) Welcomes CMS Inclusion of Key Produc - GuruFocus
Integra LifeSciences Welcomes Policy Advancements Supporting Medicare Beneficiary Access - Finviz
Integra LifeSciences Applauds CMS Ruling on Medicare Payment Schedule Benefiting Skin Substitute Products - Quiver Quantitative
Integra LifeSciences, Evolent Health, Incyte, iRhythm, and Clover Health Stocks Trade Up, What You Need To Know - Yahoo Finance
Integra LifeSciences Holdings Corporation (NASDAQ:IART) Receives Consensus Recommendation of "Reduce" from Brokerages - MarketBeat
Align Technology, Tandem Diabetes, Integra LifeSciences, Lantheus, and Inspire Medical Systems Shares Skyrocket, What You Need To Know - Barchart.com
How robust is Integra LifeSciences Holdings Corporation (IL3) stock financial positionAnalyst Downgrade & Safe Capital Preservation Plans - newser.com
Why Integra LifeSciences Holdings Corporation stock is recommended by analystsEarnings Summary Report & Weekly Stock Performance Updates - newser.com
Is Integra LifeSciences Holdings Corporation (IL3) stock vulnerable to rate hikes - newser.com
Prepare Yourself for Liftoff: Acadia Healthcare Company Inc (ACHC) - setenews.com
How institutional ownership impacts Integra LifeSciences Holdings Corporation stock2025 Year in Review & Risk Controlled Swing Trade Alerts - newser.com
Is Integra LifeSciences Holdings Corporation stock cheap at current valuation2025 Bull vs Bear & Safe Swing Trade Setups - newser.com
Does Integra LifeSciences Holdings Corporation show high probability of reboundJuly 2025 Update & Fast Gain Stock Trading Tips - newser.com
How buyback programs support Integra LifeSciences Holdings Corporation (IL3) stockTrade Analysis Report & Risk Managed Investment Signals - newser.com
FDA Grants 510(k) Clearance to Ultrasonic Surgical Aspirator System for Cardiac Surgeries - Diagnostic and Interventional Cardiology
Surgical Equipment & ConsumablesSpecialty Stocks Q3 Recap: Benchmarking Integra LifeSciences (NASDAQ:IART) - Yahoo Finance
Is Integra LifeSciences Holdings Corporation stock vulnerable to regulatory risksJuly 2025 Summary & Verified Momentum Watchlists - newser.com
Is Integra LifeSciences Holdings Corporation stock a buy for dividend growthWeekly Trade Summary & Real-Time Buy Signal Notifications - newser.com
Integra Lifesciences Holdings Corp Stock (IART) Financials Data
Revenue
Net Income
Cash Flow
EPS
Integra Lifesciences Holdings Corp Stock (IART) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Singh Harvinder | EVP & PRESIDENT, INTERNATIONAL |
Oct 12 '25 |
Option Exercise |
0.00 |
11,965 |
0 |
25,217 |
| Singh Harvinder | EVP & PRESIDENT, INTERNATIONAL |
Mar 11 '25 |
Option Exercise |
0.00 |
2,356 |
0 |
4,391 |
| Singh Harvinder | EVP & PRESIDENT, INTERNATIONAL |
Mar 10 '25 |
Option Exercise |
0.00 |
1,180 |
0 |
2,359 |
1.20%
0.48%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):